Timolol [clinicaltrials_resource:6420b4a1ec3562336d5a1a524273c038]
Prevention of Esophageal Varices by Beta-Adrenergic Blockers [clinicaltrials:NCT00006398]Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-Forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular Hypertension. [clinicaltrials:NCT00061542]Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours (0507A-137)(COMPLETED) [clinicaltrials:NCT00108017]Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular Hypertension [clinicaltrials:NCT00219596]Cosopt Versus Xalatan [clinicaltrials:NCT00273429]Assessing Cosopt Switch Patients [clinicaltrials:NCT00273442]Lumigan Versus Cosopt [clinicaltrials:NCT00273455]Cosopt Versus Xalacom [clinicaltrials:NCT00273481]A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT00287521]A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT00293787]A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT00293800]A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT00311389]A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT00314158]A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT00314171]24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients [clinicaltrials:NCT00330577]24-Hour Intraocular Pressure (IOP) Control With Travoprost/Timolol Fixed Combination [clinicaltrials:NCT00331240]A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT00333125]Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular Hypertension [clinicaltrials:NCT00348023]24-hour Intraocular Pressure (IOP) Control With Dorzolamide/Timolol and Latanoprost/Timolol Fixed Combination in Open-angle Glaucoma [clinicaltrials:NCT00397241]Visual Function Changes After Intraocular Pressure Reduction [clinicaltrials:NCT00435058]24-hour Intraocular Pressure Control With Travoprost/Timolol Fixed Combination Versus Travoprost [clinicaltrials:NCT00444184]clinicaltrials:NCT00449956A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension [clinicaltrials:NCT00465803]clinicaltrials:NCT00471068A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular Hypertension [clinicaltrials:NCT00471380]24-hour Intraocular Pressure (IOP) Control With the Bimatoprost/Timolol Fixed Combination [clinicaltrials:NCT00486486]clinicaltrials:NCT00508469Success of Transitioning Uncontrolled Glaucoma Patients From Prior Mono or Adjunctive Therapy to DuoTrav [clinicaltrials:NCT00519753]clinicaltrials:NCT00545064A Study to Evaluate the Effectiveness of Cosopt® as First Line Therapy (MK-0507A-153) [clinicaltrials:NCT00546286]Patient Preference Study [clinicaltrials:NCT00576342]Comparison of Latanoprost Vs. Timolol [clinicaltrials:NCT00579969]Adjunctive Study of AL-37807 Ophthalmic Suspension [clinicaltrials:NCT00620256]Study to Evaluate Safety of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension Patients [clinicaltrials:NCT00651612]Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension [clinicaltrials:NCT00652106]A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT00672997]Comparison of Istalol™ 0.5% QD (Timolol Maleate/Sorbitol Complex, ISTA Pharmaceutical) to Brimonidine Tartrate 0.1% BID as Adjunctive Therapy to Latanoprost 0.005% in Adults With Ocular Hypertension (OHT) or Open-Angle Glaucoma (OAG) [clinicaltrials:NCT00698945]Effect of Xalacom® (Latanoprost/Timolol) and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT00706927]clinicaltrials:NCT00716859clinicaltrials:NCT00735449
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Timolol [clinicaltrials_resource:6420b4a1ec3562336d5a1a524273c038]
Bio2RDF identifier
6420b4a1ec3562336d5a1a524273c038
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:6420b4a1ec3562336d5a1a524273c038
identifier
clinicaltrials_resource:6420b4a1ec3562336d5a1a524273c038
title
Timolol
@en
type
label
Timolol [clinicaltrials_resource:6420b4a1ec3562336d5a1a524273c038]
@en